Clinical trials of postnatal corticosteroids: Inhaled and systemic

Biology of the Neonate

Volumn 76, Issue SUPPL. 1, 1999, Pages 29-40

  Halliday, Henry L ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Postnatal steroids, inhaled, systemic; Preterm infants; Respiratory distress syndrome

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; HYDROCORTISONE; OXYGEN;

ARTIFICIAL VENTILATION; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEVELOPMENTAL DISORDER; EXTUBATION; GAS EXCHANGE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTESTINE PERFORATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOMALACIA; LUNG DEVELOPMENT; LUNG MECHANICS; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; ORAL DRUG ADMINISTRATION; OXYGEN TENSION; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; STATISTICAL ANALYSIS; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; CHRONIC DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; LUNG DISEASES; RANDOMIZED CONTROLLED TRIALS;

EID: 0033007426     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047044     Document Type: Conference Paper

References (55)

1. Jobe AH: Pulmonary surfactant therapy. N Engl J Med 1993;328: 861-868.
2. Groneck P, Speer CP: Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 1995;73: F1-F3.
3. Saugstad OD: Bronchopulmonary dysplasia and oxidative stress: Are we closer to an understanding of the pathogenesis of BPD? Acta Pediatr 1997;86:1277-1282.
4. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary develops. Pediatrics 1996;97:210-215.
5. Dreyfuss D, Saumon G: Ventilator-induced lung injury. Am J Respir Crit Care Med 1998;157:294-323.
6. Halliday HL: A review of postnatal corticosteroids for treatment and prevention of chronic lung disease in the preterm infant. Prenat Neonat Med 1997;2:1-12.
7. Bhuta T, Ohlsson A: Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease: Arch Dis Child 1998;79:F26-F33.
8. Groneck P, Reuss D, Goetze-Speer B, Speer CP: Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993;122:938-944.
9. Halliday HL, Ehrenkranz RA: Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Library, issue 1, 1999.
10. Halliday HL, Ehrenkranz RA: Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Library, issue 1, 1999.
11. Halliday HL, Ehrenkranz RA: Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Library, issue 1, 1999.
12. Baden M, Bauer CR, Cole E, Klein G, Taeusch HW, Stern L: A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 1972;50: 526-534.
13. Kopelman A, Moise A, Holbert D: A single dose of dexamethasone (Dex) given at delivery to infants <28 weeks' gestation results in improved lung function, early extubation, higher BP and less PDA (abstract 1046). Pediatr Res 1998;43:180.
14. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes PS: A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 1996;98:204-210.
15. Sanders RJ, Cox C, Phelps DL, Sinkin RA: Two doses of early intravenous dexamethasone for the prevention of the bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994;36:122-128.
16. Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S, Bader D, Yurman S, Dolfin T, Kuint J, Milbauer B, Kohelet D, Goldberg M, Armon Y, Davidson S, Sirota L, Amitai M, Zaretsky A, Barak M, Gottfried S: Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child 1996;74:F33-F37.
17. Sinkin RA, Sweck HS, Horgan MJ, Gallaher KJ, Cox C, Phelps DL, Rochester Clinical Trial Group: Early intravenous dexamethasone (Dex) for the prevention of BPD in surfactant treated babies with RDS (abstract 1138). Pediatr Res 1998;43: 195.
18. Subhedar NV, Ryan SW, Shaw MJ: Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child 1997;77: F185-F190.
19. Suske G, Oestreich K, Varnholt V, Lasch P, Kachel W: Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants. Acta Paediatr 1996;85:713-718.
20. Tapia JL, Ramirez R, Cifuentes J, Fabres J, Hubner ME, Banacalari A, Mercado ME, Standen J. Escobar M: The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr 1998;132:48-52.
21. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS: Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double blind, controlled study. J Pediatr 1990;114:273-282.
22. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH: Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: A multicenter clinical trial. Pediatrics 1997;100:E3.
23. Brozanski BS, Jones JG, Gilmoure CH, Balsan MJ, Vazquez RL, Israel BA, Newman B, Mimouni FB, Guthri RD: Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infants. J Pediatr 1995;126:769-776.
24. Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989;320: 1505-1510.
25. Durand M, Sardesai S, McEvoy C: Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birthweight infants: A randomised controlled trial. Pediatrics 1995;95: 584-590.
26. Kari MA, Heinonen K, Ikonen RS, Koivisto M, Ravio KO: Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child 1993;68:566-569.
27. Kovacs L, Davis GM, Faucher D, Papageorgiou A: Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr 1998;87:797-798.
28. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK: Multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med 1998;338: 1112-1118.
29. Ariagno RL, Sweeney TJ, Baldwin RB, Inguillo D, Martin D: Dexamethasone effects on lung function and risk in 3-week-old ventilatory dependent preterm infants (abstract). Am Rev Respir Dis 1987; 135:125.
30. Avery GB, Fletcher AB, Kaplan M, Brudno DS: Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-111.
31. Collaborative Dexamethasone Trial Group: Dexamethasone therapy in neonatal chronic lung disease: An international placebo controlled trial. Pediatrics 1991;88:421-427.
32. Harkavy KL, Scanlon JW, Chowdhry PK. Grylack LJ: Dexamethasone therapy for chronic lung disease in ventilator-and oxygen-dependent infants: A controlled trial. J Pediatr 1989;115:979-983.
33. Kazzi NJ, Brans YW, Poland RL: Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 1990;86:722-727.
34. Nobel-Jamieson CM, Regev R, Silverman M: Dexamethasone in neonatal chronic lung disease: Pulmonary effects and intracranial complications. Eur J Pediatr 1989;148:365-367.
35. Ohlsson A, Calvert SA, Hosking M, Shennan AT: Randomized controlled trial of dexamethasone treatment in very low birthweight infants with ventilator-dependent chronic lung disease. Acta Paediatr 1992;81: 751-756.
36. Vincer MJ, Allen AC: Double blind randomized trial of 6 day pulse of dexamethasone for very low birth-weight infants (VLBW <1500 grams) who are ventilator dependent at 4 weeks of age (abstract 1174). Pediatr Res 1998;43:201.
37. Abbasi S, Cole C, Frantz I, Bhutani V, Grous M, Ykoruk R, Gerdes J: Effect of early inhaled glucocorticoid therapy on lung mechanisms of ventilator dependent preterm infants (abstract 1589). Pediatr Res 1998;43:271.
38. Cole CH, Colton T, Shah BL, Abbasi S, Mackinnon BL, Demissie S, Cooper R, Frantz ID: Early inhaled glucocorticoid therapy for prevention of neonatal chronic lung disease (abstract 1629). Pediatr Res 1998;43:278.
39. Townsend SF, Hale KA, Thilo EH: Early treatment with inhaled steroids does not improve outcome in extremely premature infants with respiratory distress (abstract 1763). Pediatr Res 1998;43:300.
40. Zimmerman JJ, Kayata S, Shivpuri C, Gobbert D, Miller J, Ciesielski W: Metered-dose inhaled (MDI) beclomethasone (BEC) initiated at birth attenuates bronchoalveolar fluid (BALF) oxyradical stress in premature infants at risk for bronchopulmonary dysplasia (BPD) (abstract 1631). Pediatr Res 1997;41: 274.
41. Fok TF, Lam K, Dolovich M, Ng PC, Wong W, Cheung KL, So KW: Early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome: A randomised control study. Arch Dis Child 1999, in press.
42. Jangaard KA, Frent GA, Vincer MJ: Prophylactic inhaled beclomethasone dipropionate in infants < 1250 grams for the prevention of BPD (abstract 1030). Pediatr Res 1998;43:177.
43. Merz U, Kusenbach G, Häusler M, Peschgens T, Hörnchen H: Inhaled budesonide in ventilator-dependent preterm infants: A randomized double-blind pilot study. Biol Neonate 1999;75:46-53.
44. Giep T, Raibble P, Zuerlein T, Schwartz ID: Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. Am J Perinatol 1996;13:5-9.
45. Dunn M, Magnani L, Anaka R, Kirpalani H: Nebulised steroids for bronchopulmonary dysplasia (BPD) - a randomised, double-blind cross-over study (abstract 1192). Pediatr Res 1992;31:201.
46. Arnon S, Grigg J, Silverman M: Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: A preliminary report. Pediatr Pulmonol 1996;21:231-235.
47. La Force WR, Brudno DS: Controlled trial of beclomethasone dipropionate by nebulization in oxygen-dependent infants. J Pediatr 1993;122:285-288.
48. Suchomski SJ, Cummings JJ: Randomized trial of inhaled (INH) vs. intravenous (VI) steroid in ventilator dependent preterm infants (abstract 1468). Pediatr Res 1996;39: 247.
49. Rozycki HJ, Byron PR, Elliott GR. Carrol T, Gutcher GR: Randomized controlled trial of beclomethasone by MDI vs. systemic dexamethasone in infants at higher risk for BPD (abstract 1433). Pediatr Res 1996;39:241.
50. Dimitriou G, Greenough A, Giffin FJ, Kavadia V: Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. Eur J Pediatr 1997;156:51-55.
51. Cook RJ, Sackett DL: The number needed to treat: A clinically useful measure of treatment effect. BMJ 1995;310:452-454.
52. Jobe A: Too many unvalidated new therapies to prevent chronic lung disease in preterm infants. J Pediatr 1998;132:200-202.
53. Barrington KJ, Finer NN: Treatment of bronchopulmonary dysplasia. Clin Perinatol 1998;25:177-202.
54. Ng PC, Fok TF, Wong GWK, Lam CWK, Lee CH, Wong MY: Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment. J Clin Endocrinol Metab 1998;83:2390-2393.
55. Halliday HL: Prevention and treatment of BPD: Update 1998. Aggiorn Neonatol 1998;6:71-84.